文献速递儿童心血管与肾脏儿童神经与发育行为

心脏病儿童血栓后综合征的特征分析

Characterization of Post-Thrombotic Syndrome in Children with Cardiac Disease.
PubMed 文献 · J Pediatr · 2018-12-07

MVS筛查可行且信度可接受,准确率91%,但假阳性率高;

要点

  • MVS用于先心病儿童PTS筛查可行且信度可接受,准确率91%,但假阳性率高。
  • 确诊PTS患儿粗大运动和解决问题发育延迟率显著高于无PTS患儿。

核心结论

  • MVS用于先心病儿童PTS筛查可行且信度可接受,与临床诊断相关性好,但假阳性率高。
  • 确诊PTS患儿与无PTS患儿生活质量相似,但粗大运动和解决问题发育延迟率更高。
  • 需进一步研究确定该人群中PTS的临床意义。

研究设计与样本

  • 采用改良Villalta量表(MVS)盲法评估PTS,所有<6岁患儿接受神经发育测试和适龄生活质量评估。

主要发现

  • MVS识别轻度PTS 20例、中度PTS 1例,包括先心病/DVT组14/33(42%)、先心病/无DVT组5/37(14%)、对照组2/30(7%)。
  • 临床确诊PTS 14例,均有既往血栓史,其中1例MVS阴性。
  • MVS准确率91%,作为筛查工具表现尚可,作为诊断工具表现不佳;信度可接受。

关键数值与推荐

  • MVS识别轻度PTS 20例、中度PTS 1例。
  • 先心病/DVT组PTS 14/33(42%),先心病/无DVT组5/37(14%),对照组2/30(7%)。
  • MVS准确率91%。

临床怎么用

  • MVS可用于先心病儿童PTS筛查,但需注意假阳性率高,筛查阳性者应结合临床进一步确诊。
  • 对确诊PTS的患儿应关注粗大运动和解决问题能力的神经发育评估。

局限性

  • MVS作为诊断工具表现不佳,假阳性率高。
  • PTS在该人群中的临床意义尚需进一步研究确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the validity of existing clinical scales assessing the presence of physical and functional abnormalities for diagnosing post-thrombotic syndrome (PTS) in children, including specific evaluation of use in children with congenital heart disease (CHD). STUDY DESIGN: One hundred children aged >2 years (average age, 6 years), including 33 with CHD and previously proven extremity deep vein thrombosis (DVT), 37 with CHD and no previous DVT, and 30 healthy siblings, were blindly assessed for PTS using the modified Villalta Scale (MVS). All patients aged <6 years underwent neurodevelopmental testing and an age-appropriate quality of life assessment. RESULTS: The MVS identified mild PTS in 20 children and moderate PTS in 1 child (including 14 of 33 [42%] in the CHD/DVT group, 5 of 37 [14%] in the CHD/no DVT group, and 2 of 30 controls [7%]). The diagnosis of PTS was confirmed clinically in 14 patients, all of whom had previous thrombosis and 1 of whom was MVS-negative. MVS had an accuracy of 91% and performed reasonably well as a screening tool but poorly as a diagnostic tool. MVS reliability was acceptable. Children with PTS had similar quality of life as those without PTS but had higher rates of neurodevelopmental delays in gross motor skills (70% vs 24%; P = .02) and problem-solving indicators (60% vs 15%; P = .008). CONCLUSIONS: Using the MVS scale for PTS screening in children with CHD is feasible and reliable, and the scale has good correlation with a clinical diagnosis of PTS despite a high prevalence of false-positive findings. Further research is needed to determine the clinical relevance of PTS in this population.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Manlhiot C, McCrindle BW, Williams S, et al. Characterization of Post-Thrombotic Syndrome in Children with Cardiac Disease. J Pediatr. 2018. PMID: 30528575. doi:10.1016/j.jpeds.2018.10.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。